Vascular Biogenics Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 2.64 million compared to USD 10.43 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.13 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9601 USD | -2.13% | -1.53% | -49.20% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.20% | 8.7M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- NTBL Stock
- News Notable Labs, Ltd.
- Vascular Biogenics Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023